Genmab A/S (GNMSF) Short Interest Ratio & Short Volume $216.31 0.00 (0.00%) As of 08/8/2025 Add Compare Share Share Short Interest Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Genmab A/S Short Interest DataGenmab A/S (GNMSF) has a short interest of 69,900 shares. This marks a -16.09% decrease in short interest from the previous month. The short interest ratio (days to cover) is 699.0, indicating that it would take 699.0 days of the average trading volume of 17 shares to cover all short positions.Current Short Interest69,900 sharesPrevious Short Interest83,300 sharesChange Vs. Previous Month-16.09%Dollar Volume Sold Short$15.03 millionShort Interest Ratio699.0 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares66,070,000 sharesPercentage of Shares Shorted0.11%Today's Trading Volume10,000 sharesAverage Trading Volume17 sharesToday's Volume Vs. Average59,347% Short Selling Genmab A/S? Sign up to receive the latest short interest report for Genmab A/S and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGNMSF Short Interest Over TimeGNMSF Days to Cover Over TimeGNMSF Percentage of Float Shorted Over Time Genmab A/S Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202569,900 shares $15.03 million -16.1%N/A699 $214.95 6/30/202583,300 shares $17.58 million +86.4%0.1%833 $211.09 6/15/202544,700 shares $10.03 million -62.1%0.1%111.8 $224.30 5/31/2025117,900 shares $24.49 million -19.4%0.2%1179 $207.75 5/15/2025146,300 shares $27.62 million +98.0%0.2%43 $188.80 4/30/202573,900 shares $15.15 million +1.2%N/A246.3 $204.98 4/15/202573,000 shares $13.91 million +30.1%0.1%4.3 $190.50 3/31/202556,100 shares $10.65 million +3.9%0.1%561 $189.80 3/15/202554,000 shares $11.28 million -11.6%0.1%180 $208.89 2/28/202561,100 shares $13.75 million -23.5%0.1%203.7 $224.97 Get the Latest News and Ratings for GNMSF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. 2/15/202579,900 shares $16.86 million -1.2%0.1%21.6 $210.97 1/31/202580,900 shares $15.97 million -20.5%N/A3.8 $197.44 1/15/2025101,800 shares $20.57 million -16.6%N/A28.3 $202.06 12/31/2024122,000 shares $25.30 million +2.3%N/A16.9 $207.38 12/15/2024119,300 shares $23.98 million +9.5%N/A26.5 $201.00 11/30/2024109,000 shares $23.16 million +2.8%N/A7.2 $212.50 11/15/2024106,000 shares $22.55 million +38.9%N/A6.6 $212.71 10/31/202476,300 shares $16.67 million -10.1%N/A4.7 $218.47 10/15/202484,900 shares $19.93 million -19.1%N/A6.7 $234.80 9/30/2024104,900 shares $24.61 million -50.8%N/A80.7 $234.65 9/15/2024213,000 shares $55.32 million +3.3%N/A142 $259.72 8/31/2024206,200 shares $56.67 million +11.1%N/A114.6 $274.83 8/15/2024185,600 shares $49.24 million -1.2%N/A44.2 $265.28 7/31/2024187,900 shares $52.13 million +4.0%N/A19.4 $277.44 7/15/2024180,700 shares $46.58 million +19.5%N/A106.3 $257.77 6/30/2024151,200 shares $37.12 million +28.2%N/A116.3 $245.49 6/15/2024117,900 shares $30.47 million -0.6%N/A107.2 $258.44 5/31/2024118,600 shares $32.69 million +9.0%N/A107.8 $275.67 5/15/2024108,800 shares $31.72 million -49.4%N/A181.3 $291.54 4/30/2024214,900 shares $58.93 million +26.6%N/A126.4 $274.22 4/15/2024169,700 shares $47.86 million +7.3%N/A169.7 $282.00 3/31/2024158,100 shares $48.47 million -3.5%N/A175.7 $306.59 3/15/2024163,800 shares $49.40 million -4.1%N/A136.5 $301.60 2/29/2024170,800 shares $47.55 million +24.1%N/A27.5 $278.41 2/15/2024137,600 shares $39.55 million -11.6%N/A86 $287.40 1/15/202430,700 shares $9.65 million -4.7%N/A16.2 $314.40 12/31/202332,200 shares $10.17 million -1.5%N/A16 $315.70 12/15/202332,700 shares $10.19 million +1.6%N/A12.1 $311.50 11/30/202332,200 shares $10.27 million -42.7%N/A16.9 $319.00 11/15/202356,200 shares $18.21 million +102.2%N/A25.5 $324.07Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the September 1st funding windo 10/31/202327,800 shares $7.98 million +1.1%N/A23.2 $287.10 10/15/202327,500 shares $8.77 million +10.0%N/A45.8 $319.00 9/30/202325,000 shares $8.91 million +113.7%N/A41.7 $356.30 9/15/202311,700 shares $4.40 million -0.9%N/A7.8 $376.20 8/31/202311,800 shares $4.47 million +6.3%N/A15.6 $379.20 8/15/202311,100 shares $4.09 million -31.5%N/A27.8 $368.40 7/31/202316,200 shares $6.65 million -38.2%N/A23.1 $410.40 7/15/202326,200 shares $10.36 million -36.7%N/A18.7 $395.43 6/30/202341,400 shares $15.51 million +19.7%N/A37.6 $374.57 6/15/202334,600 shares $13.30 million -5.5%N/A38.4 $384.50 5/31/202336,600 shares $14.46 million -42.6%N/A73.2 $394.99 5/15/202363,800 shares $27.06 million +69.2%N/A91.1 $424.10 4/30/202337,700 shares $15.41 million -37.5%N/A75.4 $408.70 4/15/202360,300 shares $24.87 million -28.4%N/A67 $412.50 3/31/202384,200 shares $31.47 million -18.7%N/A210.5 $373.75 3/15/2023103,600 shares $36.80 million +143.2%N/A172.7 $355.25 2/28/202342,600 shares $15.90 million -56.0%N/A60.9 $373.25 2/15/202396,900 shares $38.21 million +8.8%N/A193.8 $394.30 1/31/202389,100 shares $34.93 million -3.3%N/A148.5 $392.00 1/15/202392,100 shares $37.12 million +37.3%N/A153.5 $403.00 12/30/202267,100 shares $28.69 million +527.1%N/A41.9 $427.50 12/15/202210,700 shares $4.77 million +78.3%N/A3.8 $445.52 11/30/20226,000 shares $2.75 million -25.0%N/A10 $457.50 11/15/20228,000 shares $3.38 million +14.3%N/A6.7 $422.43 10/31/20227,000 shares $2.69 million -51.7%N/A0.8 $384.30 10/15/202214,500 shares $5.35 million +20.8%N/A11.2 $368.80 9/30/202212,000 shares $3.84 million +10.1%N/A10.9 $320.21 9/15/202210,900 shares $3.88 million -71.7%N/A7.8 $356.25 8/31/202238,500 shares $13.59 million -31.0%N/A55 $353.01 8/15/202255,800 shares $20.85 million +30.1%N/A27.9 $373.61 7/31/202242,900 shares $14.95 million +257.5%N/A39 $348.50 7/15/202212,000 shares $4.09 million -87.2%N/A7.1 $341.16 6/30/202294,000 shares $30.58 million -30.0%N/A16.2 $325.29 6/15/2022134,200 shares $36.61 million +63.7%N/A63.9 $272.80 5/31/202282,000 shares $24.77 million -60.0%N/A8 $302.08 5/15/2022204,900 shares $59.57 million +7.1%N/A113.8 $290.75 4/30/2022191,300 shares $69.71 million +92.7%N/A273.3 $364.42 4/15/202299,300 shares $36.64 million +95.9%N/A66.2 $368.95 3/31/202250,700 shares $18.10 million -4.7%N/A56.3 $357.10 3/15/202253,200 shares $18.22 million -23.8%N/A44.3 $342.42 2/28/202269,800 shares $23.25 million +13.1%N/A34.9 $333.03 2/15/202261,700 shares $20.30 million +5.5%N/A26.8 $328.98 1/31/202258,500 shares $20.03 million +290.0%N/A26.6 $342.38 1/15/202215,000 shares $5.16 million -38.3%N/A10 $344.28 12/31/202124,300 shares $9.49 million -66.7%N/A24.3 $390.53 12/15/202172,900 shares $27.46 million +74.0%N/A11.4 $376.72 11/30/202141,900 shares $15.97 million -17.8%N/A41.9 $381.08 11/15/202151,000 shares $21.14 million +351.3%N/A85 $414.58 10/29/202111,300 shares $5.09 million -33.5%N/A7.1 $450.50 10/15/202117,000 shares $7.60 million +33.9%N/A24.3 $446.95Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the September 1st funding windo 9/30/202112,700 shares $5.37 million -11.8%N/A25.4 $423.08 9/15/202114,400 shares $6.08 million +25.2%N/A13.1 $422.08 8/31/202111,500 shares $5.49 million +0.9%N/A28.8 $477.57 8/13/202111,400 shares $5.18 million +22.6%N/A16.3 $454.38 7/30/20219,300 shares $4.17 million +34.8%N/A5.2 $448.87 7/15/20216,900 shares $3.03 million -13.8%N/A11.5 $438.47 6/30/20218,000 shares $3.38 million -31.6%N/A6.7 $422.32 6/15/202111,700 shares $5.10 million -58.4%N/A14.6 $435.68 5/28/202128,100 shares $11.52 million -64.5%N/A56.2 $409.92 5/14/202179,100 shares $29.48 million -26.7%N/A197.8 $372.72 4/30/2021107,900 shares $40.45 million +6.6%N/A269.8 $374.92 4/15/2021101,200 shares $35.77 million +19.8%N/A44 $353.50 3/31/202184,500 shares $26.73 million +14.8%N/A24.9 $316.28 3/15/202173,600 shares $23.74 million +46.0%N/A73.6 $322.50 2/26/202150,400 shares $17.39 million -40.1%N/A16.8 $345.00 2/12/202184,100 shares $34.26 million +557.0%N/A120.1 $407.32 1/29/202112,800 shares $5.26 million +12.3%N/A8 $411.00 1/15/202122,900 shares $10.04 million +97.4%N/A45.8 $438.42 12/31/202029,700 shares $12.01 million +29.7%N/A74.3 $404.45 12/15/202022,900 shares $8.95 million +97.4%N/A45.8 $390.69 11/30/202011,600 shares $4.35 million -11.5%N/A9.7 $375.01 11/15/202013,100 shares $4.81 million +13.9%N/A14.6 $366.96 10/30/202011,500 shares $3.98 million No ChangeN/A12.8 $346.21 10/15/202011,500 shares $4.43 million -35.0%N/A38.3 $385.31 9/30/202017,700 shares $6.50 million -80.7%N/A14.8 $367.16 9/15/202091,800 shares $34.27 million +37.2%N/A76.5 $373.30 8/31/202066,900 shares $25.24 million +5.5%N/A47.8 $377.29 8/14/202063,400 shares $23.14 million -11.3%N/A52.8 $365.04 GNMSF Short Interest - Frequently Asked Questions What is Genmab A/S's current short interest? Short interest is the volume of Genmab A/S shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 69,900 shares of GNMSF short. Learn More on Genmab A/S's current short interest. What is a good short interest ratio for Genmab A/S? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GNMSF shares currently have a short interest ratio of 699.0. Learn More on Genmab A/S's short interest ratio. Is Genmab A/S's short interest increasing or decreasing? Genmab A/S saw a drop in short interest during the month of July. As of July 15th, there was short interest totaling 69,900 shares, a drop of 16.1% from the previous total of 83,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Genmab A/S's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Genmab A/S: Daiichi Sankyo Co., Ltd. - Sponsored ADR (0.00%), Takeda Pharmaceutical Co. (0.14%), argenex SE (2.94%), BioNTech SE Sponsored ADR (2.55%), Summit Therapeutics PLC (3.85%), Insmed, Inc. (5.11%), Teva Pharmaceutical Industries Ltd. (4.66%), Genmab A/S Sponsored ADR (0.60%), Ascendis Pharma A/S (4.46%), Dr. Reddy's Laboratories Ltd (1.46%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Genmab A/S stock? Short selling GNMSF is an investing strategy that aims to generate trading profit from Genmab A/S as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Genmab A/S? A short squeeze for Genmab A/S occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GNMSF, which in turn drives the price of the stock up even further. How often is Genmab A/S's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNMSF, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies DSNKY Short Interest TAK Short Interest ARGX Short Interest BNTX Short Interest SMMT Short Interest INSM Short Interest TEVA Short Interest GMAB Short Interest ASND Short Interest RDY Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:GNMSF) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genmab A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Genmab A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNMSF Stock Alerts